Related Experiment Video
Updated: Mar 18, 2026

04:38
Assessment of Sexual Behavior of Male Mice
Published on: March 5, 2020
22.2K
[Mice lacking individual molecular forms of cholinesterases]
Summary
Mutant mice lacking acetylcholinesterase (AChE) or butyrylcholinesterase (BChE) have been created. Studying these mice enhances our understanding of cholinesterases and the cholinergic nervous system.
Area of Science:
- Biochemistry
- Neuroscience
- Genetics
Background:
- Cholinesterases, including acetylcholinesterase (AChE) and butyrylcholinesterase (BChE), exist in soluble or anchored forms.
- Anchoring proteins like collagen Q (ColQ) and proline-rich membrane anchor (PRiMA) are crucial for enzyme localization.
- Genetic modifications have enabled the creation of mutant mice lacking specific cholinesterase forms or anchoring proteins.
Purpose of the Study:
- To investigate the physiological and adaptive changes resulting from the absence of specific cholinesterases.
- To deepen the understanding of the roles of AChE and BChE in the cholinergic nervous system.
- To utilize genetically modified mice models for studying enzyme function.
Main Methods:
- Generation of mutant mice with targeted gene modifications affecting AChE and BChE.
- Creation of mice lacking specific molecular forms of cholinesterases (e.g., absence of AChE, absence of BChE).
- Development of mice models with deficiencies in anchoring proteins (ColQ, PRiMA) affecting cholinesterase localization.
Main Results:
- Successfully produced various mutant mouse lines with specific cholinesterase deficiencies.
- Enabled the study of adaptation mechanisms in the absence of key cholinesterase enzymes.
- Provided insights into the functions of different cholinesterase molecular forms and their anchoring proteins.
Conclusions:
- The study of cholinesterase-deficient mutant mice significantly enriches knowledge of cholinesterases.
- These models are invaluable for elucidating the complex roles of the cholinergic nervous system.
- Further research using these models will continue to advance our understanding of enzyme function and adaptation.
Related Concept Videos
Cholinesterases: Distribution and Function
1.2K
Cholinesterases are a group of serine hydrolase enzymes that play a crucial role in the breakdown of choline esters. The two primary types of cholinesterases are acetylcholinesterases (AChEs) and butyrylcholinesterase (BuChEs), which differ in their distribution, function, and substrate specificity. AChEs, also known as true cholinesterases, specifically hydrolyze acetylcholine, while BuChEs, often referred to as pseudocholinesterases, can hydrolyze various choline esters, including...
1.2K
Direct-Acting Cholinergic Agonists: Pharmacokinetics
2.0K
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
2.0K
Anticholinesterase Agents: Poisoning and Treatment
1.9K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.9K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
1.1K
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
1.1K
Indirect-Acting Cholinergic Agonists: Mechanism of Action
2.9K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
2.9K
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
2.4K
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...
2.4K

